FDA completes re-inspection of Akorn Decatur facility

LAKE FOREST - The U.S. Food and Drug Administration recently conducted a re-inspection of Akorn Inc.'s manufacturing facility in Decatur.

The re-inspection was conducted to verify the implementation and effectiveness of the specialty pharmaceutical company's responses to the observations from the June 2016 FDA inspection.